Endocrine Disruptors Acting on Estrogen and Androgen Pathways Cause Reproductive Disorders through Multiple Mechanisms: A Review

Abstract

Increasing contamination of the environment by toxic compounds such as endocrine disrupting chemicals (EDCs) is one of the major causes of reproductive defects in both sexes. Estrogen/androgen pathways are of utmost importance in gonadal development, determination of secondary sex characteristics and gametogenesis. Most of the EDCs mediate their action through respective receptors and/or downstream signaling. The purpose of this review is to highlight the mechanism by which EDCs can trigger antagonistic or agonistic response, acting through estrogen/androgen receptors causing reproductive defects that lead to infertility. In vitro, in vivo and in silico studies focusing on the impact of EDCs on estrogen/androgen pathways and related proteins published in the last decade were considered for the review. PUBMED and PUBCHEM were used for literature search. EDCs can bind to estrogen receptors (ERα and ERβ) and androgen receptors or activate alternative receptors such as G protein-coupled receptors (GPCR), GPR30, estrogen-related receptor (ERRγ) to activate estrogen signaling via downstream kinases. Bisphenol A, dichlorodiphenyltrichloroethane, dichlorodiphenyldichloroethylene, polychlorinated biphenyls and phthalates are major toxicants that interfere with the normal estrogen/androgen pathways leading to infertility in both sexes through many ways, including DNA damage in spermatozoids, altered methylation pattern, histone modifications and miRNA expression.

Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment

“…In men, this is chased by CA prostate 13.5% and colorectal carcinoma 10.9% for frequency and liver carcinoma 10.2% and gastric carcinoma 9.5% for death. Carcinoma of the breast is the most frequently identified cancer in women [ 10 ] and cancer is the most widespread in 154 out of the one hundred and eighty-five countries included in GLOBOCAN 2018 [ 42 ]. Carcinoma of the breast is also the principal cause of cancer demise in women i.e., 15%, followed by pulmonary carcinoma 13.8% and colorectal carcinoma 9.5%, which are also the 3 rd and 2 nd most widespread types of cancer, correspondingly; CA Cervix ranks 4 th for both frequency (6.6%) and death (7.5%) [ 43 ].…”

A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review)

“…In patients suffering from ovarian cancer, it was also demonstrated that obesity negatively affects the prognosis of patients leading to therapeutic failure and worse overall survival time ( 7 ). As widely described for other tumors such as breast and prostate cancer ( 8 , 9 ), besides these physiological variations of hormone levels, occupational and environmental risk factors as well as endocrine disruptors and other chemical substances have been associated with the development of ovarian cancer ( 10 - 13 ).…”

Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action

“…DDT and its metabolites such as DDE bioaccumulate up the food chain. DDT and DDE act as nuclear estrogen receptor agonists (DDT), androgen receptor antagonist (DDE), and can also bind to certain GPCRs, which can cause alter estrogen signaling ( 111 ). DDT has been shown in mouse models to affect the sympathetic nervous system that innervates both BAT and WAT.…”